Evotec (EVO) News Today $4.11 +0.07 (+1.73%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Evotec (NASDAQ:EVO) Shares Down 3.6% - Here's WhyEvotec (NASDAQ:EVO) Stock Price Down 3.6% - Time to Sell?January 16 at 6:48 PM | marketbeat.comShort Interest in Evotec SE (NASDAQ:EVO) Rises By 89.9%Evotec SE (NASDAQ:EVO - Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 766,200 shares, a growth of 89.9% from the December 15th total of 403,500 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily trading volume, of 232,100 shares, the short-interest ratio is presently 3.3 days.January 14, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Down 3.6% - Here's What HappenedEvotec (NASDAQ:EVO) Shares Down 3.6% - Time to Sell?January 14, 2025 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up - Here's WhyEvotec (NASDAQ:EVO) Shares Gap Up - Still a Buy?January 2, 2025 | marketbeat.comEvotec: Some Recovery Has Come, But Much More Is ExpectedDecember 29, 2024 | seekingalpha.comEvotec (NASDAQ:EVO) Shares Gap Down - What's Next?Evotec (NASDAQ:EVO) Shares Gap Down - What's Next?December 27, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Trading Down 3% - Time to Sell?Evotec (NASDAQ:EVO) Trading Down 3% - What's Next?December 26, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Trading Up 9.4% - What's Next?Evotec (NASDAQ:EVO) Trading 9.4% Higher - Still a Buy?December 24, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Down - Here's WhyEvotec (NASDAQ:EVO) Shares Gap Down - Time to Sell?December 18, 2024 | marketbeat.comEvotec SE (NASDAQ:EVO) Short Interest Down 10.7% in NovemberEvotec SE (NASDAQ:EVO - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 401,600 shares, a decline of 10.7% from the November 15th total of 449,700 shares. Based on an average trading volume of 197,200 shares, the short-interest ratio is presently 2.0 days. Approximately 0.1% of the shares of the stock are sold short.December 17, 2024 | marketbeat.comWellington Management Group LLP Buys 602,858 Shares of Evotec SE (NASDAQ:EVO)Wellington Management Group LLP lifted its position in Evotec SE (NASDAQ:EVO - Free Report) by 29.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,634,434 shares of the company's stock after purchasing an additional 602December 16, 2024 | marketbeat.comEQS-News: Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo NordiskDecember 11, 2024 | markets.businessinsider.comEvotec And Novo Nordisk Launch Projects For LAB EN² Drug Discovery AcceleratorDecember 11, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?Evotec (NASDAQ:EVO) Shares Gap Down - Here's WhyDecember 6, 2024 | marketbeat.comEvotec Chief Operating Officer to step down on December 31November 29, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Stock Price Down 2.7% - Here's WhyEvotec (NASDAQ:EVO) Shares Down 2.7% - Should You Sell?November 29, 2024 | marketbeat.comEvotec COO Craig Johnstone Steps DownNovember 29, 2024 | marketwatch.comHalozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cashNovember 24, 2024 | markets.businessinsider.comSan Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offerNovember 24, 2024 | msn.comEvotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Here's What HappenedEvotec (NASDAQ:EVO) Sees Large Volume Increase - Still a Buy?November 22, 2024 | marketbeat.comHalozyme withdraws $2.1 bln buyout offer for EvotecNovember 22, 2024 | reuters.comHalozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in DiscussionsNovember 22, 2024 | prnewswire.comSan Diego biotech Halozyme makes $2.1B bid for German drugmakerNovember 21, 2024 | msn.comIs Evotec SE (EVO) the Best German Stock to Buy Now?November 19, 2024 | insidermonkey.comEvotec (NASDAQ:EVO) Shares Gap Down - Here's What HappenedEvotec (NASDAQ:EVO) Shares Gap Down - Here's WhyNovember 19, 2024 | marketbeat.comDeutsche Bank Remains a Sell on Evotec (0IRF)November 18, 2024 | markets.businessinsider.comHalozyme Provides Update on Non-Binding Proposal to Combine with EvotecNovember 18, 2024 | prnewswire.comEvotec SE (NASDAQ:EVO) Sees Significant Decrease in Short InterestEvotec SE (NASDAQ:EVO - Get Free Report) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 220,100 shares, a decline of 10.7% from the October 15th total of 246,500 shares. Based on an average daily volume of 138,900 shares, the short-interest ratio is presently 1.6 days. Currently, 0.1% of the shares of the stock are sold short.November 18, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Here's What HappenedEvotec (NASDAQ:EVO) Sees Strong Trading Volume - Still a Buy?November 15, 2024 | marketbeat.comEvotec jumps as Halozyme confirms takeover interest (updated)November 14, 2024 | seekingalpha.comHalozyme Therapeutics Bids to Acquire German Competitor EvotecNovember 14, 2024 | marketwatch.comHalozyme Therapeutics Proposes To Acquire Evotec For EUR 11.00/shr In CashNovember 14, 2024 | markets.businessinsider.comHalozyme interested in acquiring Evotec for $2.1B, Bloomberg saysNovember 14, 2024 | markets.businessinsider.comEvotec jumps on report Halozyme expressed takeover interestNovember 14, 2024 | msn.comGermany’s Evotec Gets Takeover Interest From HalozymeNovember 14, 2024 | bloomberg.comHalozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash TransactionNovember 14, 2024 | prnewswire.comHalozyme weighing buyout of drugmaker Evotec, Bloomberg News reportsNovember 14, 2024 | reuters.comEvotec Third Quarter 2024 Earnings: Misses ExpectationsNovember 12, 2024 | finance.yahoo.comEQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionNovember 11, 2024 | markets.businessinsider.comWhat is HC Wainwright's Forecast for Evotec FY2024 Earnings?Evotec SE (NASDAQ:EVO - Free Report) - Stock analysts at HC Wainwright cut their FY2024 earnings per share estimates for shares of Evotec in a research report issued to clients and investors on Thursday, November 7th. HC Wainwright analyst D. Tsao now expects that the company will post earnings oNovember 11, 2024 | marketbeat.comEarnings Release: Here's Why Analysts Cut Their Evotec SE (ETR:EVT) Price Target To €10.65November 10, 2024 | finance.yahoo.comWhat is HC Wainwright's Estimate for Evotec Q1 Earnings?Evotec SE (NASDAQ:EVO - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for Evotec in a research report issued on Thursday, November 7th. HC Wainwright analyst D. Tsao expects that the company will earn ($0.01) per share for the quarter. HC Wainwright cNovember 8, 2024 | marketbeat.comDeutsche Bank Sticks to Their Sell Rating for Evotec (0IRF)November 8, 2024 | markets.businessinsider.comEvotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic InitiativesNovember 8, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $8.00 price target on shares of Evotec in a report on Thursday.November 7, 2024 | marketbeat.comEvotec SE (EVOTF) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...November 7, 2024 | finance.yahoo.comEvotec SE (EVO) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comJefferies Sticks to Their Hold Rating for Evotec (0IRF)November 6, 2024 | markets.businessinsider.comEvotec AG Strengthens Alliances Amidst Revenue ChallengesNovember 6, 2024 | markets.businessinsider.comEvotec SE 2024 Q3 - Results - Earnings Call PresentationNovember 6, 2024 | seekingalpha.com Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address EVO Media Mentions By Week EVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼0.920.64▲Average Medical News Sentiment EVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼43▲EVO Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Legend Biotech News Elanco Animal Health News Cytokinetics News Nuvalent News Grifols News TG Therapeutics News Viking Therapeutics News Axsome Therapeutics News Krystal Biotech News Organon & Co. News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVO) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
